If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
444.70    -2.70 (-0.60%)
Bid:
444.60
Ask:
444.80
Spread: 0.20 (0.045%)
Market Cap: £11.19b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

4 Mar 2021 07:05

RNS Number : 1024R
Rentokil Initial PLC
04 March 2021
 

4 March 2021

 

 

Directorate Changes including Appointment of Non-Executive Director

 

Rentokil Initial plc (FTSE: RTO, "the Company") today announces the appointment of Sarosh Mistry to its Board as a Non-Executive Director with effect from 1 April 2021. Sarosh will also become a member of the Remuneration Committee and the Nomination Committee from this date.

 

Sarosh has extensive experience as a senior executive, driving organic and inorganic growth in business-to-business services, especially in North America. He has deep experience of building businesses across the healthcare, retail, facilities management, hospitality, financial services and consumer technology industries, including innovation-led growth, service line extensions and new country entries (including emerging markets in Latin America and Asia). His executive experience has been in complex, geographically dispersed and multi-site businesses operating globally.

 

Sarosh is Chairman of Sodexo's North American services, which include clinical technology in health care settings, SaaS-based digital ecosystems, and food-focused delivery. He is also CEO of Sodexo's global Home Care Services business and a member of the listed group's executive committee. Prior to joining Sodexo in 2011, he worked in senior roles in major business-to-business and consumer organisations Compass, Starbucks, Aramark and Pepsico. Sarosh has a Bachelor's degree from St John's University, and a MBA from the A. Gary Anderson Graduate School of Management.

 

Commenting on the appointment Richard Solomons, Chairman, said:

 

"We are delighted to welcome Sarosh to the Board of Rentokil Initial. He has a track record of leading transformative growth and success in major support services businesses in our largest market, North America, as well as globally. We are confident that his experience and personal qualities will enable him to make a strong contribution to the Board." 

 

There are no further details to be disclosed relating to Sarosh Mistry under Section 9.6.13 of the Listing Rules.

 

Other Board Changes

 

Angela Seymour-Jackson, Non-Executive Director and Chair of the Remuneration Committee, has informed the Company that, having served on the Board for a period of 9 years, she does not intend to stand for re-election at the Company's AGM on 12 May 2021 and will, therefore, retire as a director of the Company from the conclusion of the meeting. The Company is pleased to announce that Cathy Turner, a Non-Executive Director and member of the Remuneration Committee since April 2020, will succeed Angela as Chair of the Remuneration Committee.

 

Commenting on the changes to Board, Richard Solomons, Chairman of Rentokil Initial, said: "I would like to thank Angela for her very significant contribution to the Board since she joined it in 2012, and for her work on the Remuneration Committee including as Chair since 2019. I'd also like to congratulate Cathy on her new appointment."

 

 

For further information please contact:

 

Rentokil Initial plc

 

Media

Malcolm Padley

07788 978199

Company Secretary

Daragh Fagan

07990 561702

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUCUWUPGPGW
Date   Source Headline
6th Oct 20051:05 pmRNSRule 8.3- Rentokil Initial
6th Oct 200512:51 pmRNSRule 8.3- Rentokil
6th Oct 200512:00 pmRNSRule 8.3- Rentokil Init PLC
6th Oct 200511:43 amRNSEPT Disclosure
6th Oct 200510:49 amRNSRule 8.3-Rentokil Initial Plc
5th Oct 20054:17 pmRNSEPT Disclosure - Amendment
5th Oct 20051:18 pmRNSRule 8.3- Rentokil Initial
5th Oct 200511:39 amRNSEPT Disclosure
5th Oct 200511:20 amRNSRule 8.3- Rentokil Init PLC
5th Oct 200511:04 amRNSRule 8.3-Rentokil Initial PLC
5th Oct 20059:55 amRNSRule 8.3-Rentokil Initial PLC
4th Oct 20056:22 pmRNSEPT Disclosure - Amendment
3rd Oct 20056:28 pmRNSEPT Disclosure - Amendment
3rd Oct 20053:43 pmRNSRule 8.3-Rentokil Initial Plc
3rd Oct 20051:01 pmRNSEPT Disclosure
3rd Oct 200512:06 pmRNSEPT Disclosure - CFD
3rd Oct 200512:03 pmRNSRule 8.3-Rentokil Initial Plc
3rd Oct 200511:06 amRNSRule 8.3- Rentokil Init PLC
30th Sep 20052:00 pmRNSHolding(s) in Company
30th Sep 20051:29 pmRNSRule 8.3-Rentokil Initial PLC
30th Sep 200512:46 pmRNSRule 8.3-Rentokil Initial PLC
30th Sep 200511:49 amRNSRule 8.3- Rentokil
30th Sep 200511:45 amRNSEPT Disclosure - CFD
30th Sep 200511:28 amRNSEPT Disclosure
30th Sep 200510:19 amRNSRule 8.3- Rentokil Initial
29th Sep 200512:21 pmRNSEPT Disclosure
29th Sep 200511:55 amRNSRule 8.3-Rentokil Initial PLC
29th Sep 200511:48 amRNSRule 8.3- Rentokil
29th Sep 200511:22 amRNSRule 8.3-Rentokil Initial Plc
29th Sep 200511:06 amRNSRule 8.3- Rentokil Initial
29th Sep 200510:37 amRNSInitial Style Conferences
29th Sep 200510:13 amRNSRule 8.3- Rentokil Initial
28th Sep 200512:19 pmRNSEPT Disclosure - CFD
28th Sep 200512:03 pmRNSRule 8.3-Rentokil Initial PLC
28th Sep 200512:01 pmRNSEPT Disclosure
28th Sep 200511:23 amRNSRule 8.3- Rentokil Initial PL
28th Sep 200510:30 amRNSRule 8.3- Rentokil Initial
28th Sep 200510:13 amRNSRule 8.3-Rentokil Initial PLC
27th Sep 20055:31 pmRNSEPT Disclosure - Amendment
27th Sep 200512:53 pmRNSEPT Disclosure
27th Sep 200511:35 amRNSRule 8.3- Rentokil Initial
27th Sep 200510:27 amRNSRule 8.3- Rentokil Init PLC
27th Sep 20058:33 amRNSRule 2.10 Announcement
26th Sep 200512:50 pmRNSRule 8.3- (Rentokil Initial)
26th Sep 200512:21 pmRNSEPT Disclosure
26th Sep 200510:40 amRNSRule 8.3- Rentokil Init PLC
26th Sep 200510:25 amRNSRule 8.3- Rentokil Initial
23rd Sep 20053:24 pmRNSEPT Disclosure Amendment
23rd Sep 200512:36 pmRNSEPT Disclosure - CFD
23rd Sep 200512:26 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.